Italia markets closed

Organovo Holdings, Inc. (0R02.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,3220+0,2856 (+27,56%)
Alla chiusura: 04:19PM BST
Schermo intero
Caricamento grafico interattivo in corso...
  • GlobeNewswire

    Organovo to Participate in the H.C. Wainwright Global Investment Conference

    SAN DIEGO, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (Organovo), a clinical stage biotechnology company that is focused on developing novel human therapies with high fidelity in three-dimensional (3D) human tissues that recapitulate key aspects of human disease, today announced that Keith Murphy, Founder and Executive Chairman, will present a corporate update and hold meetings with institutional investors during the H.C. Wainwright 25th Annual Global Investment Co

  • GlobeNewswire

    Organovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 Data

    SAN DIEGO, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (Organovo), a clinical stage biotechnology company that is focused on developing novel human therapies with demonstrated function in high fidelity three-dimensional (3D) tissues that recapitulate key aspects of human disease, today announced more details about its clinical program for FXR314, an FXR agonist that has completed initial clinical trials. FXR314 is a drug with safety and tolerability after daily oral